Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Unknown 2

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Sarcoma 1

Conditions

Ovarian Neoplasms 18Testicular Neoplasms 13Testicular Germ Cell Tumor 9Sarcoma 9Teratoma 6Central Nervous System Neoplasms 6Neuroectodermal Tumors, Primitive, Peripheral 5Endodermal Sinus Tumor 5Seminoma 4Ovarian Germ Cell Cancer 4Osteosarcoma 4Liposarcoma 4Kidney Neoplasms 4Hemangiosarcoma 4Fibrosarcoma 4Carcinoma, Embryonal 4Wilms Tumor 3Sarcoma, Synovial 3Sarcoma, Endometrial Stromal 3Neurofibrosarcoma 3Malignant mesenchymal tumor 3Leiomyosarcoma 3Histiocytoma, Malignant Fibrous 3Hemangiopericytoma, Malignant 3Desmoplastic Small Round Cell Tumor 3Carcinoma, Ovarian Epithelial 3Uterine Cervical Neoplasms 2Pheochromocytoma 2Optic Nerve Glioma 2Neuroblastoma 2

Interventions

Carboplatin 159Paclitaxel 153Bevacizumab 85Taxes 48Gemcitabine 48liposomal doxorubicin 47Topotecan 41Cisplatin 35pembrolizumab 33Cyclophosphamide 28olaparib 25Immunoglobulin G 24Disulfides 24Specimen Handling 21Drug Therapy 20Docetaxel 20niraparib 18Magnetic Resonance Spectroscopy 18Doxorubicin 17Biopsy 15mirvetuximab soravtansine 14Hyperthermic Intraperitoneal Chemotherapy 14rucaparib 13Nivolumab 12Cytoreduction Surgical Procedures 11Chemotherapy, Adjuvant 10Albumin-Bound Paclitaxel 10veliparib 9Platinum 9Neoadjuvant Therapy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Fallopian Tube Neoplasms × Ifosfamide × Gynecologic × Clear all
NCT00954174 2021-09-30

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

GOG Foundation

Phase 3 Unknown
637 enrolled 18 charts
GynecologicSarcoma

Carcinosarcoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00045461 2013-08-07

Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

National Cancer Institute (NCI)

Phase 2/3 Unknown
241 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡